Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders (AND1)
Sponsor: Mayo Clinic
A observational or N/A phase clinical study on Apraxia of Speech and Behavioral Variant of Frontotemporal Dementia, this trial is ongoing. The trial is conducted by Mayo Clinic and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Enrolling By Invitation
-
Dec 2024 — Dec 2025 [monthly]
Enrolling By Invitation
-
Sep 2024 — Dec 2024 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Jun 2024 — Jul 2024 [monthly]
Enrolling By Invitation
▶ Show 5 earlier versions
-
Jun 2023 — Jun 2024 [monthly]
Enrolling By Invitation
-
May 2023 — Jun 2023 [monthly]
Enrolling By Invitation
-
May 2022 — May 2023 [monthly]
Enrolling By Invitation
Status: Recruiting → Enrolling By Invitation
-
Jan 2022 — May 2022 [monthly]
Recruiting
-
Jan 2021 — Jan 2022 [monthly]
Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .